Structure Therapeutics GPCR Ratios (2023-2026)

NASDAQ GPCR
$47.34 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Structure Therapeutics Quarterly Ratios

Periods 14 quarters
Latest Jun 2026

Structure Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 0.17B0.24B0.22B0.35B0.47B0.70B0.94B0.92B0.88B0.84B0.82B1.21B1.55B1.47B
Valuation
Price to EarningsP/E -95.15-205.00-242.88-817.26-230.23-258.83-221.87-443.72-63.80-58.09-77.56247.69-135.28-108.02
Price to BookP/B 7.2422.2630.049.9213.957.328.415.393.624.646.629.757.108.47
Enterprise Value 1.36B4.36B5.44B3.69B5.22B5.27B5.88B3.07B1.47B2.16B3.60B12.69B7.68B9.05B
EV to EBIT -68.96-167.93-207.90-119.13-163.02-158.05-128.29-65.27-26.04-30.60-48.81529.08-85.88-76.32
EV to EBITDA -68.96-167.93-207.90-119.13-163.02-158.05-128.29-65.27-26.04-30.60-48.81529.08-85.88-76.32
Market Capitalization 1.71B4.77B5.80B4.49B5.99B6.74B7.54B4.66B2.99B3.58B5.10B14.78B10.28B11.47B
Price to FCFP/FCF -83.98-280.30-271.12-196.27-175.05-240.55-382.83-117.25-56.14-65.52-97.98-255.23988.52-73.72
EV to FCF -66.53-256.31-254.27-161.34-152.42-187.98-298.61-77.27-27.55-39.44-69.24-219.17738.34-58.21
EV to CFO -66.73-258.31-264.41-169.92-153.14-199.51-298.55-84.23-28.07-39.51-70.63-197.03503.86-75.38
Return Ratios
Return on Capital Employed [ROCE]ROCE -36.67%-31.91%-41.78%-31.68%-25.81%-18.02%-15.68%-17.93%-21.51%-27.37%-32.29%-15.42%-14.08%-18.41%
Return on Assets [ROA]ROA -32.60%-27.52%-34.57%-20.22%-16.75%-11.60%-9.74%-10.51%-13.26%-18.18%-22.41%-9.48%-9.29%-12.83%